Home NDC 70518-3548 Rexulti
Product NDC 70518-3548
11-digit product format 705183548
Labeler code 70518
Product ID 70518-3548_502002a4-924a-5370-e063-6394a90a9717
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name brexpiprazole
Dosage form TABLET
Route ORAL
Labeler REMEDYREPACK INC.
Application NDA205422
Marketing category NDA
Marketing start 2022-10-03
Substance BREXPIPRAZOLE
Active strength 2 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 20 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70518-3548-0 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70518-3548-0 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70518-3548-0 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70518-3548-0 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70518-3548-0 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70518-3548-0 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70518-3548-0 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70518-3548-0 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70518-3548-0 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 70518-3548-0 ad56d346431e…cc804d4bbf1e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205422-001 REXULTI BREXPIPRAZOLE 0.25MG TABLET / ORAL AB RLD 2015-07-10 N205422-002 REXULTI BREXPIPRAZOLE 0.5MG TABLET / ORAL AB RLD 2015-07-10 N205422-003 REXULTI BREXPIPRAZOLE 1MG TABLET / ORAL AB RLD 2015-07-10 N205422-004 REXULTI BREXPIPRAZOLE 2MG TABLET / ORAL AB RLD, RS 2015-07-10 N205422-005 REXULTI BREXPIPRAZOLE 3MG TABLET / ORAL AB RLD 2015-07-10 N205422-006 REXULTI BREXPIPRAZOLE 4MG TABLET / ORAL AB RLD 2015-07-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 76 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 30 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205422-001 REXULTI 0.25MG TABLET / ORAL AB RLD 2015-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 REXULTI 0.5MG TABLET / ORAL AB RLD 2015-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 REXULTI 1MG TABLET / ORAL AB RLD 2015-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-004 REXULTI 2MG TABLET / ORAL AB RLD, RS 2015-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-005 REXULTI 3MG TABLET / ORAL AB RLD 2015-07-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-006 REXULTI 4MG TABLET / ORAL AB RLD 2015-07-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-001 REXULTI 0.25MG TABLET / ORAL AB RLD 2015-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-002 REXULTI 0.5MG TABLET / ORAL AB RLD 2015-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-003 REXULTI 1MG TABLET / ORAL AB RLD 2015-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-004 REXULTI 2MG TABLET / ORAL AB RLD, RS 2015-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-005 REXULTI 3MG TABLET / ORAL AB RLD 2015-07-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205422-006 REXULTI 4MG TABLET / ORAL AB RLD 2015-07-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205422-001 REXULTI 0.25MG TABLET / ORAL AB RLD 2015-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205422-002 REXULTI 0.5MG TABLET / ORAL AB RLD 2015-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205422-003 REXULTI 1MG TABLET / ORAL AB RLD 2015-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205422-004 REXULTI 2MG TABLET / ORAL AB RLD, RS 2015-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205422-005 REXULTI 3MG TABLET / ORAL AB RLD 2015-07-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205422-006 REXULTI 4MG TABLET / ORAL AB RLD 2015-07-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-001 REXULTI 0.25MG TABLET / ORAL AB RLD 2015-07-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-002 REXULTI 0.5MG TABLET / ORAL AB RLD 2015-07-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-003 REXULTI 1MG TABLET / ORAL AB RLD 2015-07-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-004 REXULTI 2MG TABLET / ORAL AB RLD, RS 2015-07-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-005 REXULTI 3MG TABLET / ORAL AB RLD 2015-07-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205422-006 REXULTI 4MG TABLET / ORAL AB RLD 2015-07-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-001 REXULTI 0.25MG TABLET / ORAL AB RLD 2015-07-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-002 REXULTI 0.5MG TABLET / ORAL AB RLD 2015-07-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-003 REXULTI 1MG TABLET / ORAL AB RLD 2015-07-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-004 REXULTI 2MG TABLET / ORAL AB RLD, RS 2015-07-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-005 REXULTI 3MG TABLET / ORAL AB RLD 2015-07-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205422-006 REXULTI 4MG TABLET / ORAL AB RLD 2015-07-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-001 REXULTI 0.25MG TABLET / ORAL RLD 2015-07-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-002 REXULTI 0.5MG TABLET / ORAL RLD 2015-07-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-003 REXULTI 1MG TABLET / ORAL RLD 2015-07-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-004 REXULTI 2MG TABLET / ORAL RLD, RS 2015-07-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-005 REXULTI 3MG TABLET / ORAL RLD 2015-07-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205422-006 REXULTI 4MG TABLET / ORAL RLD 2015-07-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205422-001 REXULTI 0.25MG TABLET / ORAL RLD 2015-07-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205422-002 REXULTI 0.5MG TABLET / ORAL RLD 2015-07-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205422-003 REXULTI 1MG TABLET / ORAL RLD 2015-07-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205422-004 REXULTI 2MG TABLET / ORAL RLD, RS 2015-07-10 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 132 observed states.
Observed Orange Book patent history# Patent history page 1 of 63 · 2,519 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205422-001 7888362 2026-04-12 Drug substance, Delist requested 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 8349840 2026-04-12 U-1529 Drug product 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 8618109 2026-04-12 U-543 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 8618109 2026-04-12 U-3281 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 9839637 2026-04-12 U-1529 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 9839637 2026-04-12 U-3281 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 9839637 2026-04-12 U-543 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 7888362*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 8349840*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 8618109*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 9839637*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 RE48059 2028-12-23 Drug substance 2020-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 RE48059*PED 2029-06-23 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 10307419 2032-10-12 Drug product 2019-06-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-001 10307419*PED 2033-04-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 7888362 2026-04-12 Drug substance, Delist requested 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 8349840 2026-04-12 U-1529 Drug product 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 8618109 2026-04-12 U-543 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 8618109 2026-04-12 U-3281 2015-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 9839637 2026-04-12 U-543 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 9839637 2026-04-12 U-1529 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 9839637 2026-04-12 U-3281 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 7888362*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 8349840*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 8618109*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 9839637*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 RE48059 2028-12-23 Drug substance 2020-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 RE48059*PED 2029-06-23 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 10307419 2032-10-12 Drug product 2019-06-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-002 10307419*PED 2033-04-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 7888362 2026-04-12 Drug substance, Delist requested 2015-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 8349840 2026-04-12 U-1529 Drug product 2015-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 8618109 2026-04-12 U-543 2015-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 8618109 2026-04-12 U-3281 2015-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 9839637 2026-04-12 U-1529 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 9839637 2026-04-12 U-543 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 9839637 2026-04-12 U-3281 Drug product 2018-01-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 7888362*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 8349840*PED 2026-10-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205422-003 8618109*PED 2026-10-12 Pediatric extension 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 16 · 612 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Rexulti
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BREXPIPRAZOLE 2 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2J3YBM1K8C Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1658335 Internal RxNorm lookup 1658337 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 70518-3548-0 70518354800 1 BOTTLE in 1 CARTON (70518-3548-0) > 30 TABLET in 1 BOTTLE 1 bottle 2022-10-03 0000-00-00 No No Current 70518-3548-1 70518354801 50 POUCH in 1 BOX (70518-3548-1) / 1 TABLET in 1 POUCH (70518-3548-2) 50 pouch 2026-04-22 No No Current 70518-3548-2 70518354802 1 in 1 POUCH Historical